GEA GROUP

TickerG1A.XETRA
Current Price –
GEA GROUP – stock chart

5-year stock timeline

2026-08–09 (Q2 2026 / guidance raise and capital return)

GEA reported Q2 2026 results with record profitability, raised full-year 2026 guidance and announced a material capital-return program. The market reframed GEA as accelerating from a stable industrial-to-food-processing growth story toward a higher-quality, cash-returning compounder as margins hit new highs. Investors rewarded the stronger margin outlook and buyback signal as evidence of disciplined capital allocation and cyclical resilience.

Q2 2026 sales reached €1,442 million with EBITDA before restructuring expenses of €250.6 million, yielding an EBITDA margin before restructuring expenses of 17.4%, a company record. Q2 order intake was €1,495 million, up 14.2% year-on-year or 15.4% organic. Full-year 2026 guidance was raised to organic sales growth of 6–8% and EBITDA margin before restructuring expenses of 17.0–17.4%, up from prior guidance of 5–7% and 16.6–17.2% [8][2][6].

2026-09-21 (Preliminary FY-2025 results and FY-2026 guidance reaffirmation)

GEA published preliminary full-year 2025 figures showing higher sales, order intake and EBITDA than guidance, and reaffirmed FY-2026 targets. Confirmation that 2025 execution was stronger than expected reinforced investor confidence in management's growth-plus-margin narrative and set a positive backdrop for 2026 execution. Perception shifted toward consistent profitable growth rather than one-off margin spikes.

FY-2025 order intake was €5.92 billion, organic growth of 9.1%, with sales of €5.50 billion, organic growth of 3.7%. Preliminary EBITDA before restructuring expenses reached €907 million, representing a margin of 16.5%. EPS was projected at €2.60–2.70 for FY-2025. FY-2026 guidance called for organic sales growth above 5%, later raised to 6–8%, with further margin improvement [1][2][12].

2026-08 (Mid-2026 analyst coverage / market commentary)

Analysts and media reported GEA beat Q2 estimates on EPS and revenue, with several outlets noting record margins and buyback plans. Broad coverage and analyst upgrades bolstered the view that GEA had re-rated from a cyclical equipment supplier to a structurally improving margin compounder with attractive capital returns.

Reported EPS approximated $0.79 for Q2 2026 on USD-converted feeds, with revenue of $1.44 billion versus analyst estimates around $1.38 billion [6][8][9].

2025 (FY-2025 results, published March 2026 annual report)

GEA reported full-year 2025 results showing profitable growth, higher margins and stronger order intake. Management set out FY-2026 ambitions for mid-single-digit organic growth and margin improvement. Investors saw FY-2025 as validation of the "Mission 26" transformation, focused on higher-margin segments, services and capital efficiency. The company's mix shift and margin progress supported a narrative of durable improvement rather than temporary cyclical gains.

FY-2025 sales reached €5.495 billion with order intake of €5.924 billion. EBITDA before restructuring expenses was €907 million, with an EBITDA margin of 16.5% and EPS before restructuring of €2.74. The company guided FY-2026 organic growth of 5–7% and EBITDA margin of 16.6–17.2%, later raised [5][12].

2024 (Achievement of mid-term targets and 2030 ambitions announced)

GEA announced it had achieved mid-term financial targets under Mission 26 ahead of schedule and communicated an ambitious plan toward 2030 including sustainability and climate goals. This milestone reframed GEA from a recovery/cost-focus story into a growth plus sustainability story. Investors increasingly credited management with predictable execution and long-term capital discipline.

Management cited ROCE improvements and margin targets achieved, with ROCE approximating 32.7% for 2023 referenced in AGM remarks [30][23].

Nov 2023 → early 2025 (Share buyback program(s) and capital-return actions)

GEA launched a multi-tranche share buyback program announced in November 2023 for up to €400 million to be completed by early 2025, with repurchases continuing into 2024 and further tranches executed. The buybacks signaled management's confidence in cash generation and improved returns to shareholders. The market interpreted repurchases and planned cancellations as supportive to EPS and a sign of balance-sheet strength, shifting perception toward shareholder-friendly capital allocation.

The first tranche in November 2023 repurchased 1,451,583 shares for approximately €50 million by end-December 2023. The company disclosed total repurchases in early tranches of 3,765,457 shares worth approximately €135.47 million reported at AGM commentary, with further tranches announced totaling €400 million [18][23][16].

2023 (FY-2023 results; CEO/CFO and portfolio moves)

FY-2023 results showed revenue growth to €5,373.5 million with EBITDA before restructuring expenses rising to €774 million. GEA appointed Bernd Brinker as CFO effective October 16, 2023 and announced small strategic bolt-on tech acquisitions including CattleEye, alongside the new €400 million buyback program. Results showed resilience amid currency headwinds. Management changes and targeted acquisitions supported a narrative of professionalized capital allocation and selective tech-enabled-services expansion to lift recurring and service revenues.

FY-2023 order intake was €5,469.4 million, reported at −3.7% versus 2022 or organic +0.8%, with revenue of €5,373.5 million, up 4.0% reported. EBITDA before restructuring expenses reached €774 million, yielding a margin of approximately 14.4%. EPS was €2.28 reported, with EPS before restructuring of €2.56. Initial buyback repurchases totaled approximately 1.45 million shares for €50 million by end-2023 [18][22][23].

2022 (Post-COVID recovery, Mission 26 launch and margin focus)

GEA executed strategic program "Mission 26" focused on portfolio optimization, efficiency and margin improvement. 2022 results reflected recovery from pandemic disruptions and clearer mid-term targets. Investors began to view GEA as moving from a cyclical equipment supplier toward higher-quality, service-and-technology-enhanced solutions with targetable margins. The company's disciplined capital and margin targets improved credibility with long-term holders.

Company disclosures in 2022 and 2023 referenced mid-term targets for ROCE and margin uplift, setting the base for later outperformance. FY-2022 order intake was €5,678.9 million with revenue of €5,164.7 million, referenced in subsequent 2023 releases [18][25].

2021 (Mission 26 launch / strategic reset — origin of mid-term targets)

GEA established mid-term strategic plan "Mission 26" with explicit financial targets for margin, ROCE and growth that framed its actions through the subsequent five years. At the time, investors treated Mission 26 as the company's reset: an attempt to move up the value chain into higher-margin offerings and services, improve capital efficiency and lift returns. This multi-year transformation set expectations for the 2022–2026 performance window.

The plan spelled out mid-term objectives that management later said were met ahead of schedule. These targets became the benchmark for subsequent margin and ROCE reporting in later annual reports and presentations [30][12].

Key risks and downside factors

GEA Group supplies engineering and technology systems globally to food, beverage, dairy, pharmaceutical, and chemical processors. The company competes against large diversified engineering groups with overlapping portfolios, specialized niche players, and lower-cost Asian competitors in process equipment and integrated systems—heat transfer, separation, filling, packaging, and process skids among them. The business faces headwinds from cyclical capital spending patterns, competitive margin pressure, regulatory and food-safety compliance requirements, and volatility in supply-chain costs and raw-material pricing [8], [3].

  • GEA's equipment demand follows the capital spending cycles of its food, beverage, and pharmaceutical customers, creating volatility in both order intake and revenue.
  • Large diversified competitors and low-cost Asian manufacturers create persistent margin pressure through pricing compression on standardized equipment.
  • Regulatory and product-safety risk stems from potential failures or noncompliance in hygienic and aseptic systems, which could trigger recalls, expose the company to liability, and damage reputation across food and pharmaceutical end markets.
  • Supply-chain and input-cost risk: disruptions or spikes in steel, electronics, and component availability can drive up project costs and push back deliveries, which pressures both margins and the backlog.

Competitive landscape

GEA Group is a German engineering company that builds process technology and equipment for food, beverage, dairy, pharmaceutical and chemical industries. Its main competitors supply heat-transfer systems, separation equipment, filling and packaging machinery, and complete processing lines—names like Alfa Laval, Krones, SPX Flow, JBT, and IMA. The company also faces competition from larger industrial engineering groups and private packaging specialists. The business carries exposure to cyclical capital spending patterns, competitive pressure on margins, fluctuating component and commodity costs, supply chain and project execution risks, and the regulatory demands that come with serving food and pharmaceutical sectors.

CompanyTicker
Krones AGKRN.XETRA
JBT CorporationJBT.NYSE
IMA S.p.A.IMA.MI

Private competitors

  • Tetra Pak (part of Tetra Laval Group)
  • Coesia S.p.A. (private Italian packaging/automation group)
  • Various specialist private skid/system integrators and regional OEMs (China/India)

Get More Stock Analyses Like This

Receive hand-picked stock recommendations with detailed analyses every week

Start Free Trial

Performance Figures of GEA GROUP

in EUR

1M High / Low
69.35 / 63.15
52W High / Low
69.35 / 53.45
5Y High / Low
69.35 / 31.18
1M
+6.87%
3M
+13.89%
6M
+12.43%
1Y
+11.80%
3Y
+114.43%
5Y
+96.72%

Relative Performance vs Benchmarks

PeriodGEA GROUP vs DAX vs S&P 500 (SPY)
1M +6.87% +8.72% +5.11%
3M +13.89% +13.75% +11.12%
6M +12.43% +6.98% -2.05%
1Y +11.80% +9.80% -4.76%
3Y +114.43% +51.68% +29.75%
5Y +96.72% +31.64% +7.74%

Get More Stock Analyses Like This

Receive hand-picked stock recommendations with detailed analyses every week

Start Free Trial

Historical valuation trends

How the company’s key valuation ratios (P/E, P/S, P/B and P/CF) have evolved over time compared to today.

PeriodP/E RatioP/S RatioP/B RatioP/CF Ratio
Current25.31.94.415.2
1Y ago25.21.94.615.9
3Y ago13.31.12.411.8
5Y ago36.51.53.59.7

Frequently Asked Questions

Where is the GEA GROUP stock traded?

The GEA GROUP stock trades under the ticker G1A.XETRA on the XETRA exchange. ISIN: DE0006602006.

What does GEA GROUP do?

GEA GROUP is a company characterized by the following investment thesis:

What are the key metrics for G1A.XETRA?

Key metrics for G1A.XETRA include valuation (P/E 25.3, P/S 1.9, P/B 4.3), profitability (profit margin 7.70%, ROE 18.45%), and growth (revenue –, earnings –). Market capitalization is 10.82B EUR. These metrics give an overview of the company's financial performance and valuation.

How has GEA GROUP's stock price performed?

GEA GROUP's stock has returned – over 1 year, – over 3 years, and – over 5 years. Performance can vary depending on market conditions and company developments.

How is G1A.XETRA valued?

G1A.XETRA has the following valuation metrics: P/E Ratio: 25.3, P/S Ratio: 1.9, P/B Ratio: 4.3. These metrics help assess whether the stock is fairly valued compared to its fundamentals.

Does G1A.XETRA pay dividends?

Yes, G1A.XETRA pays dividends with a dividend yield of 1.9%. Dividends can be an important component of the total return on an investment.

What are the key risks when investing in G1A.XETRA?

Key risks for G1A.XETRA include: GEA Group supplies engineering and technology systems globally to food, beverage, dairy, pharmaceutical, and chemical processors. The company competes against large diversified engineering groups with overlapping portfolios, specialized niche players, and lower-cost Asian competitors in process equipment and integrated systems—heat transfer, separation, filling, packaging, and process skids among them. The business faces headwinds from cyclical capital spending patterns, competitive margin pressure, regulatory and food-safety compliance requirements, and volatility in supply-chain costs and raw-material pricing [8, 3, 21].
  • GEA's equipment demand follows the capital spending cycles of its food, beverage, and pharmaceutical customers, creating volatility in both order intake and revenue.
  • Large diversified competitors and low-cost Asian manufacturers create persistent margin pressure through pricing compression on standardized equipment.
  • Regulatory and product-safety risk stems from potential failures or noncompliance in hygienic and aseptic systems, which could trigger recalls, expose the company to liability, and damage reputation across food and pharmaceutical end markets.
  • Supply-chain and input-cost risk: disruptions or spikes in steel, electronics, and component availability can drive up project costs and push back deliveries, which pressures both margins and the backlog.
Investors should consider these risk factors carefully before making an investment decision.

Who are the main competitors of GEA GROUP?

GEA GROUP competes with several listed peers in its sector. GEA Group is a German engineering company that builds process technology and equipment for food, beverage, dairy, pharmaceutical and chemical industries. Its main competitors supply heat-transfer systems, separation equipment, filling and packaging machinery, and complete processing lines—names like Alfa Laval, Krones, SPX Flow, JBT, and IMA. The company also faces competition from larger industrial engineering groups and private packaging specialists. The business carries exposure to cyclical capital spending patterns, competitive pressure on margins, fluctuating component and commodity costs, supply chain and project execution risks, and the regulatory demands that come with serving food and pharmaceutical sectors.
  • Krones AG (KRN.XETRA)
  • JBT Corporation (JBT.NYSE)
  • IMA S.p.A. (IMA.MI)
These competitors influence pricing power, growth opportunities and relative valuation.

When does GEA GROUP report earnings?

GEA GROUP's next earnings report date is November 9, 2026.

Key Metrics

Market Capitalization
10.82B EUR
P/E Ratio
25.32
Analyst Target Price
–

Valuation Metrics

P/S Ratio
1.92
P/B Ratio
4.33

Profitability Metrics

Profit Margin
7.70%
Operating Margin
12.51%
Return on Equity
18.45%
Return on Assets
6.86%

Growth Metrics

Revenue Growth
–
Earnings Growth
–

Dividend history

Long-term record of paid dividends (amount per share and dividend yield at the time of payment).

YearDividendYield at paymentAvg. yield
20261.30 EUR2.20%2.17%
20251.15 EUR2.01%
20241.00 EUR2.64%
20230.95 EUR2.20%
20220.90 EUR2.40%
20210.85 EUR2.33%
20200.43 EUR1.48%
20200.42 EUR2.00%
20190.85 EUR3.34%
20180.85 EUR2.46%
20170.80 EUR2.07%
20160.80 EUR1.90%
20150.70 EUR1.53%
20140.60 EUR1.86%
20130.55 EUR2.16%

Earnings history & estimates

Historical earnings performance shows how consistently the company meets or exceeds analyst expectations. Forward estimates provide insight into expected profitability and growth trajectory.

Historical earnings performance

34.9%
Beat estimate
60.3%
Miss estimate
+16.58%
Avg surprise when beat
-22.36%
Avg surprise when miss

Reports analyzed: 63

Upcoming earnings report

November 9, 2026
Next earnings date

Analyst estimates for upcoming periods

Next year
December 31, 2027
Consensus3.74
Range3.41 – 4.08
15 analysts
Est. growth vs prior: 11.15%
Revisions: 7d ↑1 ↓0 · 30d ↑4 ↓0
Next quarter
September 30, 2024
Consensus0.69
Range0.67 – 0.72
2 analysts
Est. growth vs prior: -4.2%

Key financial figures

All figures in EUR

Selected income statement, balance sheet and cash flow figures. Annual and quarterly, based on reported IFRS/GAAP financials.

20252024202320222021
Revenue5.50B5.42B5.37B5.16B4.70B
Operating income (EBIT)639.78M593.03M504.90M466.88M380.90M
Net income414.01M385.04M392.76M401.43M305.17M
Free cash flow472.94M473.01M305.21M265.53M552.15M
Total assets6.09B6.03B5.95B5.92B5.87B
Equity2.45B2.42B2.40B2.28B2.08B
Net debt-378.94M-326.14M-367.19M-329.97M-499.66M
© Leeway
PWP Leeway UG (haftungsbeschränkt)
Leeway Icon